Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance

Drug resistance is a huge hurdle in tumor therapy. Tumor hypoxia contributes to chemotherapy resistance by inducing the hypoxia-inducible factor-1α (HIF-1α) pathway. To reduce tumor hypoxia, novel approaches have been devised, providing significant importance to reverse therapeutic resistance and improve the effectiveness of antitumor therapies. Herein, the nanosystem of bovine serum albumin (BSA)-templated manganese dioxide (MnO2) nanoparticles (BSA/MnO2 NPs) loaded with doxorubicin (DOX) (DOX-BSA/MnO2 NPs) developed in our previous report was further explored for their physicochemical properties and capacity to reverse DOX resistance because of their excellent photothermal and tumor microenvironment (TME) response effects. The DOX-BSA/MnO2 NPs showed good biocompatibility and hemocompatibility. Meanwhile, DOX-BSA/MnO2 NPs could greatly affect DOX pharmacokinetic properties, with prolonged circulation time and reduced cardiotoxicity, besides enhancing accumulation at tumor sites. DOX-BSA/MnO2 NPs can interact with H2O2 and H+ in TME to form oxygen and exhibit excellent photothermal effect to further alleviate hypoxia due to MnO2, reversing DOX resistance by down-regulating HIF-1α expression and significantly improving the antitumor efficiency in DOX-resistant human breast carcinoma cell line (MCF-7/ADR) tumor model. The hypoxia-ameliorated photothermal MnO2 platform is a promising strategy for revering DOX resistance.

[1]  Lianhua Cui,et al.  Photothermal effects of CuS-BSA nanoparticles on H22 hepatoma-bearing mice , 2022, Frontiers in Pharmacology.

[2]  Tianjiao Li,et al.  A supramolecular nano-delivery system based on AIE PARP inhibitor prodrug and glycosylated pillar[5]arene for drug-resistance therapy. , 2022, Chemical communications.

[3]  Jindong Li,et al.  Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway , 2022, Neoplasia.

[4]  Yihua Yang,et al.  Biomimetic ZIF8 Nanosystem With Tumor Hypoxia Relief Ability to Enhance Chemo-Photothermal Synergistic Therapy , 2022, Frontiers in Pharmacology.

[5]  Jialiang Zhang,et al.  Photothermal MnO2 Nanoparticles Boost Chemo-photothermal Therapy-induced Immunogenic Cell Death in Tumor Immunotherapy. , 2022, International journal of pharmaceutics.

[6]  Qiwei Tian,et al.  Engineering of an endogenous hydrogen sulfide responsive smart agent for photoacoustic imaging-guided combination of photothermal therapy and chemotherapy for colon cancer , 2022, Journal of advanced research.

[7]  Jun Wu,et al.  A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia , 2021, Journal of Hematology & Oncology.

[8]  Zhe-Sheng Chen,et al.  Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers , 2021, Advanced materials.

[9]  S. Samani,et al.  Synthesis, cytotoxicity assay, pharmacokinetics, biodistribution and modeling study of cabazitaxel-dextran nanoconjugates: targeted vs non targeted delivery. , 2021, Colloids and surfaces. B, Biointerfaces.

[10]  Xu Chen,et al.  A hybrid nanozymes in situ oxygen supply synergistic photothermal/chemotherapy of cancer management. , 2021, Biomaterials science.

[11]  Jinlu Liu,et al.  Tumor hypoxia-activated combinatorial nanomedicine triggers systemic antitumor immunity to effectively eradicate advanced breast cancer. , 2021, Biomaterials.

[12]  Yu Wang,et al.  Recent progress in nanomedicine for enhanced cancer chemotherapy , 2021, Theranostics.

[13]  T. Gong,et al.  Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer , 2021, Asian journal of pharmaceutical sciences.

[14]  Xiaole Qi,et al.  Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use , 2021, Journal of advanced research.

[15]  Zhipeng Chen,et al.  Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma. , 2021, Carbohydrate polymers.

[16]  J. Zou,et al.  A hybrid semiconducting organosilica-based O2 nanoeconomizer for on-demand synergistic photothermally boosted radiotherapy , 2021, Nature Communications.

[17]  Y. Xin,et al.  Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy , 2021, Journal of Experimental & Clinical Cancer Research.

[18]  R. Minchin,et al.  Hypoxia-mediated drug resistance in breast cancers. , 2020, Cancer letters.

[19]  Weicai Wang,et al.  Biomineralization: An Opportunity and Challenge of Nanoparticle Drug Delivery Systems for Cancer Therapy , 2020, Advanced healthcare materials.

[20]  R. Donnelly,et al.  Bacterially sensitive nanoparticle-based dissolving microneedles of doxycycline for enhanced treatment of bacterial biofilm skin infection: A proof of concept study , 2020, International journal of pharmaceutics: X.

[21]  Yong Hu,et al.  An Oxygen Self‐Evolving, Multistage Delivery System for Deeply Located Hypoxic Tumor Treatment , 2019, Advanced healthcare materials.

[22]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[23]  Peilong Cao,et al.  Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  Xin Liang,et al.  Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Ziqi Ye,et al.  A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  F. Acartürk,et al.  Fabrication of doxycycline-loaded electrospun PCL/PEO membranes for a potential drug delivery system. , 2019, International journal of pharmaceutics.

[27]  X. Shuai,et al.  Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy , 2019, Advanced science.

[28]  Wen-jun Wang,et al.  Hydrangea-structured tumor microenvironment responsive degradable nanoplatform for hypoxic tumor multimodal imaging and therapy. , 2019, Biomaterials.

[29]  Qingbo Xu,et al.  pH- and photothermal-driven multistage delivery nanoplatform for overcoming cancer drug resistance , 2019, Theranostics.

[30]  Jong Seung Kim,et al.  Hypoxia-targeted drug delivery. , 2019, Chemical Society reviews.

[31]  B. Meibohm,et al.  Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells. , 2019, Journal of colloid and interface science.

[32]  B. Qiu,et al.  Ultra‐small Albumin Templated Gd/Ru Composite Nanodots for In Vivo Dual modal MR/Thermal Imaging Guided Photothermal Therapy , 2018, Advanced healthcare materials.

[33]  J. Pokorski,et al.  pH Responsive Doxorubicin Delivery by Fluorous Polymers for Cancer Treatment. , 2018, Molecular pharmaceutics.

[34]  Jinping Wang,et al.  All-in-One Theranostic Nanoplatform Based on Hollow MoSx for Photothermally-maneuvered Oxygen Self-enriched Photodynamic Therapy , 2018, Theranostics.

[35]  Liangzhu Feng,et al.  Intelligent Albumin-MnO2 Nanoparticles as pH-/H2 O2 -Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy. , 2018, Advanced materials.

[36]  Zhuang Liu,et al.  Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses , 2017, Nature Communications.

[37]  Quan P. Ly,et al.  MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. , 2017, Cancer cell.

[38]  Liangzhu Feng,et al.  Intelligent Albumin–MnO2 Nanoparticles as pH‐/H2O2‐Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy , 2016, Advanced materials.

[39]  S. Påhlman,et al.  Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. , 2016, Pharmacology & therapeutics.

[40]  E. Rankin,et al.  Hypoxic control of metastasis , 2016, Science.

[41]  Roger Liang,et al.  Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model , 2015, Journal of Nanobiotechnology.

[42]  R. Sankar,et al.  Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[43]  Andreas M. Nyström,et al.  Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance. , 2014, Biomaterials.

[44]  T. Cramer,et al.  Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[45]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[46]  N. Desai.  Nanoparticle albumin bound (nab) technology: targeting tumors through the endothelial gp60 receptor and SPARC , 2007 .

[47]  D. Averill-Bates,et al.  Multidrug-resistant hela cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide. , 2004, International journal of radiation oncology, biology, physics.